Arnold & Porter is expanding its IP practice in London with Beatriz San Martin, who joined the team last week as partner. San Martin joins from the Lo ...
A new era is dawning in the German Federal Court of Justice. Peter Meier-Beck has had his last trial as presiding judge of the patent senate. In the d ...
Patent holder Brahms has won the next round in the long-standing dispute over procedures for detecting infections. The Federal Patent Court has dismis ...
Amgen has achieved another success in the dispute over a compulsory licence for two competing cholesterol-lowering drugs. Düsseldorf Regional Court up ...
EIP has bolstered its patent litigation group with the hire of a new partner. Kathleen Fox Murphy joins the firm from UK-based law firm Browne Jacobse ...
The German Federal Court of Justice has declared AstraZeneca's formulation patent EP 1 250 138 for the breast cancer drug fulvestrant null and void. T ...
A patent for the drug tadalafil has been ruled as invalid by the UK Supreme Court. Upholding a Court of Appeal decision, the patent EP (UK) 1173 181, ...
Rheumatism drug Humira is one of pharmaceutical company AbbVie's most valuable biosimilars. In ongoing disputes over the patent family, the European P ...
Munich patent law firm Müller Schupfner & Partner has strengthened its chemical practice with the hire of Christoph Heinemann (49) as a partner. Heine ...
It was planned for the SPC manufacturing waiver to be introduced in the EU before 2019. However, the final report by the Committee for Legal Affairs ( ...
Global healthcare company Novartis has won a High Court judgment against Dr Reddy’s Laboratories over a treatment for breast cancer. An interim injunc ...
Second medical use is currently a hot topic in pharmaceutical patents. In the dispute over the breast cancer drug containing the active ingredient ful ...
Düsseldorf patent litigation firm Wildanger has won its eighth partner. Alexander Reetz, previously counsel at Hogan Lovells, joined Wildanger at the ...
From the UK’s Supreme Court FRAND decision, to the first case over connected cars in Germany, and patents for pioneering scientific breakthroughs – th ...
After rebutting a demand for compulsory licences concerning its cholesterol-lowering drug Repatha, US pharmaceutical company Amgen has now successfull ...
